Opposite changes of 2HG and Glx levels in mutant IDH1 glioma (i.e., high 2HG and low Glx tumor levels) may make the 2HG/Glx ratio a metabolic biomarker that has an increased range to detect mutant IDH1 tumor tissue. Here, IDH1 is linked to neoplasm.